1Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025

---

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8

Commonwealth Coat of Arms of Australia

 

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025

I, Nicholas Henderson, as delegate of the Minister for Health and Ageing, make the following instrument.

Dated 18  December 2025

Nicholas Henderson

First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health, Disability and Ageing

 

 

 

Contents

1  Name

2  Commencement

3  Authority

4  Definitions

5  Declaration of serious scarcity

6  Substitution of scarce medicine by pharmacists

7  Period instrument is in force

8  Repeals

Schedule 1—Scarce medicine, substitutable medicine, dose unit equivalence and specific permitted circumstances

Schedule 2—General permitted circumstances

 

1  Name

  This instrument is the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025.

2  Commencement

 (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

• Commencement information
• Column 1 Column 2 Column 3
• Provisions Commencement Date/Details
• 1. The whole of this instrument 22 December 2025. 22 December 2025

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under section 30EK of the Therapeutic Goods Act 1989.

4  Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following: